-
Now Serving Patients:
Civica Rx announces its first
medicine has been produced,
packaged, ordered, delivered
and is now available to patients.Patients are being treated with Civica's Vancomycin, an essential antibiotic that is often in short supply.
40 health systems and philanthropies are now a part of Civica, including:
.
Advocate Aurora Health
Allegheny Health Network
Aspirus Health System
Baptist Health
Baptist Health South Florida
Christiana Care Health System
CommonSpirit Health
Franciscan Alliance
Gary and Mary West Foundation
Hospital Corporation of America (HCA)
Hospital Sisters Health System
Integris Health
Intermountain Healthcare
Laura and John Arnold Foundation
Mayo Clinic
MemorialCare
Memorial Hermann
New Hanover Regional Medical Center
North Memorial Hospital
NYU Langone Health
Ochsner Health System
Peterson Center on Healthcare
Piedmont Health
Providence St. Joseph Health
Regional One Health
Sanford Health
Southeast Georgia Health System
Spectrum Health
SSM Health
St. Clair Hospital
Steward Health Care System
St. Luke's University Health Network
The Christ Hospital
ThedaCare
Trinity Health
UnityPoint Health
University of Utah Health
Recent News
Civica Rx and Exela Pharma Sciences Join Forces
Civica Rx and Exela Pharma Sciences Join Forces to Provide Sodium Bicarbonate to Hospitals Across the U.S. The partnership will help stabilize supply of a vital medicine used daily for emergency care. Civica Rx and Exela Pharma Sciences, today announce a long-term agreement to manufacture and supply Civica's growing membership of U.S. health systems...
Civica Rx Celebrates Its First Birthday!
Overheard at a recent Congressional Hearing on the reliability of the global generic drug supply chain: “I think it is fascinating to watch what the private sector hospitals in the United States are doing…they formed a nonprofit called Civica Rx in response to persistent shortages of vital life-saving medicines…and they are doing direct contracting with trustworthy manufacturers…with...
Hikma and Civica Rx Sign Long-term Agreement
Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company and Civica Rx, today announce a five-year agreement to manufacture and supply Civica's growing membership of US health systems with medications that are often in short supply in US hospitals. Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica as a private...
Civica will partner with healthcare systems to ensure that generic drugs are affordable and available as soon as possible.
We will partner with hospitals and healthcare systems to (1) prioritize production of generic drugs and (2) purchase Civica generic drugs, based on hospital systems’ clinical needs.
- We will create market stability by procuring or manufacturing the products required by our hospital systems
- We will guarantee volumes for our hospitals and health system partners for each drug we manufacture
Civica will focus on bringing value — in supply, quality, and price — to the market
- We will establish long-term partnerships that will allow us to guarantee predictable, long-term supply
- We will provide our suppliers with long-term, predictable volumes
- We will work with trusted, FDA-approved manufacturers with high-quality track records. We will embed a collaborative, rigorous quality assurance process with each partner and will have a single price point for each drug, regardless of health system size
- We will assure that our prices are transparent and competitive
Civica will serve as a check in the generic manufacturing industry
- We will fix broken markets by applying for Abbreviated New Drug Applications (ANDA) for each drug we manufacture
- We will have the R&D expertise necessary to enter identified drug markets and develop medications that our patients need
- We will partner with our governmental and regulatory agencies to assure we are working together in a way that benefits our patients